Edward Wild is a professor of neurology, consultant neurologist at the National Hospital for Neurology and Neurosurgery, Queen Square, and associate director of UCL Huntington’s Disease Centre.
He studied medicine at Cambridge University, and has worked in clinical neurology and HD research since 2005. He obtained MRCP in 2005 and specialty certification in 2015. His PhD research on biomarkers and inflammation in HD was undertaken at UCL with Prof Tabrizi, and won the 2009 Queen Square Prize in Neurology. He has also won the 2012 Huntington Society of Canada Community Leadership Award, the 2014 Huntington's Disease Society of America Researcher of the Year Award, and the 2014 UCL Institute of Neurology Lecturer of the Year award.
Huntington’s disease encompasses biomarkers, clinical and translational research, and clinical trials including huntingtin-lowering (“gene silencing”) therapies.
Professor Wild won the 2009 Queen Square Prize in Neurology; the 2012 Huntington Society of Canada Community Leadership Award; the 2014 Huntington's Disease Society of America Researcher of the Year Award; UCL Institute of Neurology Lecturer of the Year Awards in 2013, 2014 and 2017; and Huntington Study Group Insight of the Year awards in 2015 and 2017.
Professor Wild has authored over 80 peer-reviewed publications and 6 book chapters (for full list, see here).